Murphy Polly A.
SEC insider (Form 3/4/5 filer). CIK 0001829248. Director at Atea Pharmaceuticals, Inc. (AVIR) and 1 other issuer. 18 reported Form 4/5 transactions since Sep 2024; latest on Jun 18, 2026. Located in MINNEAPOLIS, MN.
Companies Murphy Polly A. has filed insider reports for
- Atea Pharmaceuticals, Inc. (AVIR): Director
- Celcuity Inc. (CELC): Director
Murphy Polly A.
CIK: 0001829248
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (18 total)
- Jun 18, 2026AVIR
Atea Pharmaceuticals, Inc.
AwardDirectStock Option (Right to Buy)
37.7K shares- - Jun 18, 2026AVIR
Atea Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
26.7K shares- - Jun 18, 2026AVIR
Atea Pharmaceuticals, Inc.
ExerciseDirect29.6K shares- - Jun 10, 2026CELC
Celcuity Inc.
GiftIndirectStock Option (right to buy)
14K shares- - Jun 10, 2026CELC
Celcuity Inc.
GiftDirectStock Option (right to buy)
14K shares- - Jun 5, 2026CELC
Celcuity Inc.
AwardDirect1.5K shares- - May 18, 2026AVIR
Atea Pharmaceuticals, Inc.
PurchaseDirect6.1K shares at avg. $4.17$25K - Jun 20, 2025AVIR
Atea Pharmaceuticals, Inc.
ExerciseDirect29.6K shares- - Jun 20, 2025AVIR
Atea Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
29.6K shares- - Jun 20, 2025AVIR
Atea Pharmaceuticals, Inc.
AwardDirectStock Option (Right to Buy)
41.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 18, 2026 |  AVIR Atea Pharmaceuticals, Inc. | Award Stock Option (Right to Buy) | 37,700 | - | - | Direct |
| Jun 18, 2026 | AVIR Atea Pharmaceuticals, Inc. | Award Restricted Stock Units | 26,700 | - | - | Direct |
| Jun 18, 2026 | AVIR Atea Pharmaceuticals, Inc. | Exercise | 29,600 | - | $0 | Direct |
| Jun 10, 2026 |  CELC Celcuity Inc. | Gift Stock Option (right to buy) | 14,048 | - | - | Indirect |
| Jun 10, 2026 | CELC Celcuity Inc. | Gift Stock Option (right to buy) | 14,048 | - | - | Direct |
| Jun 5, 2026 | CELC Celcuity Inc. | Award | 1,530 | - | $0 | Direct |
| May 18, 2026 | AVIR Atea Pharmaceuticals, Inc. | Purchase | 6,100 | $4.17 | $25,446 | Direct |
| Jun 20, 2025 | AVIR Atea Pharmaceuticals, Inc. | Exercise | 29,600 | - | - | Direct |
| Jun 20, 2025 | AVIR Atea Pharmaceuticals, Inc. | Award Restricted Stock Units | 29,600 | - | - | Direct |
| Jun 20, 2025 | AVIR Atea Pharmaceuticals, Inc. | Award Stock Option (Right to Buy) | 41,200 | - | - | Direct |
1-10 of 18 transactions